Clinical trial · Observational
Prognostic Nomogram of Extranodal NK/T-cell Lymphoma
Prognostic Nomogram of Extranodal NK/T-cell Lymphoma: A Multi-center Retrospective Study
NCT04554511CI-TRIAL-00067258unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to evaluate prognostic factors for overall survival and explore risk progression-free survival in ENKTL, and establish a prognostic predictive nomogram for ENKTL patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Extranodal NK/T-cell Lymphoma | Nasal Type Extranodal NK/T-Cell Lymphoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Training cohort
- description
- Patients diagnosed with ENKTL, between January 1, 2000 and August 31, 2020.
- label
- Validation Cohort
- description
- Patients diagnosed with ENKTL, between January 1, 2000 and August 31, 2020.
Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- 5 year
- description
- Time between the date of diagnosis and any kinds of death
Secondary outcomes (1)
- measure
- Progression-free survival
- timeFrame
- 5 year
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients newly diagnosed with ENKTL * Patients diagnosed between January 1, 2000 and August 31, 2020 * Patients older than 18 years Exclusion Criteria: * Patients who did not have complete clinical information or immunohistochemistry, or who were lost follow-up immediately after treatment.
References
Publications (0)
Data not yet available
No reference posted for this study.